These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 31118602)

  • 21. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
    Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
    Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2009 Sep; 4(9):1083-93. PubMed ID: 19652625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Worse Prognosis for Stage IA Lung Cancer Patients with Smoking History and More Severe Chronic Obstructive Pulmonary Disease.
    Yoshida Y; Kage H; Murakawa T; Sato Y; Ota S; Fukayama M; Nakajima J
    Ann Thorac Cardiovasc Surg; 2015; 21(3):194-200. PubMed ID: 25641032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
    Ajimizu H; Ozasa H; Sato S; Funazo T; Sakamori Y; Nomizo T; Kuninaga K; Ogimoto T; Hosoya K; Yamazoe M; Tsuji T; Yoshida H; Itotani R; Ueno K; Kim YH; Muro S; Hirai T
    Sci Rep; 2021 Dec; 11(1):23677. PubMed ID: 34880386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.
    Sohn HS; Kwon JW; Shin S; Kim HS; Kim H
    J Clin Pharm Ther; 2015 Dec; 40(6):661-71. PubMed ID: 26573867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study.
    Park HY; Kang D; Shin SH; Yoo KH; Rhee CK; Suh GY; Kim H; Shim YM; Guallar E; Cho J; Kwon OJ
    Thorax; 2020 Jun; 75(6):506-509. PubMed ID: 32241883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Combined Chronic Obstructive Pulmonary Disease Status and Systemic Inflammation on Outcome of Advanced NSCLC: Multicenter Retrospective Cohort Study.
    Lim JU; Kang HS; Yeo CD; Kim JS; Park CK; Kim YH; Kim JW; Kim SJ; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3323-3334. PubMed ID: 33363365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
    Park HJ; Byun MK; Rhee CK; Kim K; Kim HJ; Yoo KH
    Respir Res; 2018 Sep; 19(1):185. PubMed ID: 30249256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
    Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study.
    Sood A; Petersen H; Qualls C; Meek PM; Vazquez-Guillamet R; Celli BR; Tesfaigzi Y
    Respir Res; 2016 Nov; 17(1):147. PubMed ID: 27832774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A; Cerfolio RJ
    Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea.
    Lee SJ; Kim SW; Kong KA; Ryu YJ; Lee JH; Chang JH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():497-506. PubMed ID: 25784796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases.
    Kondo R; Yoshida K; Eguchi T; Kobayashi N; Saito G; Hamanaka K; Shiina T; Kurai M
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1439-43. PubMed ID: 21530296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
    Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
    Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
    Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD).
    Ng Kee Kwong F; Nicholson AG; Pavlidis S; Adcock IM; Chung KF
    BMC Cancer; 2018 Dec; 18(1):1238. PubMed ID: 30526542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.